X-Chromosome Loss of Heterozygosity Frequently Occurs in Gastrinomas and Is Correlated with Aggressive Tumor Growth

Yuan Jia Chen, Alexander Vortmeyer, Zhengping Zhuang, Fathia Gibril, Robert T. Jensen

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

BACKGROUND. Recent studies have shown that tumor growth, rather than hormone overproduction, is the leading cause of death among patients with gastrinomas and other malignant gastrointestinal endocrine tumors. No patient/laboratory characteristics accurately predict which tumors will exhibit aggressive growth. Furthermore, little is known regarding the molecular pathogenesis of these tumors. X-chromosome loss of heterozygosity (LOH) occurs in some nonendocrine tumors, and its presence can be associated with aggressive growth/decreased survival. Data on X-chromosome LOH in gastrointestinal endocrine tumors are conflicting. Therefore, the purpose of the current study was to determine whether X-chromosome LOH occurred in gastrinomas and, if so, whether it was correlated with tumor growth, tumor behavior, and/or prognosis. METHODS. X chromosome allelotyping was performed using 12 microsatallite markers spaced throughout the chromosome using DNA from leukocytes and microdissected gastrinoma specimens from 16 female patients. The presence of X-chromosome LOH was analyzed for correlations with clinical and laboratory tumor characteristics as well as tumor growth characteristics. RESULTS. Nine gastrinoma specimens (56%) had X-chromosome LOH, ranging from 6% to 23% at the 12 different loci studied. X-chromosome LOH was significantly associated with aggressive postoperative tumor growth, increased primary tumor size, and pancreatic primaries. In 6 tumor specimens, LOH occurred on Xp22.1-22.3 over a 28.4-centimorgan region. CONCLUSIONS. X-chromosome LOH was common in gastrinoma specimens from female patients, and its presence was found to be a potentially useful molecular/genetic prognostic factor for aggressive growth.

Original languageEnglish (US)
Pages (from-to)1379-1387
Number of pages9
JournalCancer
Volume100
Issue number7
DOIs
StatePublished - Apr 1 2004
Externally publishedYes

Fingerprint

Gastrinoma
Loss of Heterozygosity
X Chromosome
Growth
Neoplasms

Keywords

  • Loss of heterozygosity
  • Pancreatic endocrine tumors
  • Prognosis
  • Zollinger-Ellison syndrome

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

X-Chromosome Loss of Heterozygosity Frequently Occurs in Gastrinomas and Is Correlated with Aggressive Tumor Growth. / Chen, Yuan Jia; Vortmeyer, Alexander; Zhuang, Zhengping; Gibril, Fathia; Jensen, Robert T.

In: Cancer, Vol. 100, No. 7, 01.04.2004, p. 1379-1387.

Research output: Contribution to journalArticle

Chen, Yuan Jia ; Vortmeyer, Alexander ; Zhuang, Zhengping ; Gibril, Fathia ; Jensen, Robert T. / X-Chromosome Loss of Heterozygosity Frequently Occurs in Gastrinomas and Is Correlated with Aggressive Tumor Growth. In: Cancer. 2004 ; Vol. 100, No. 7. pp. 1379-1387.
@article{308a2903bb4442efa71afc33ceddbf18,
title = "X-Chromosome Loss of Heterozygosity Frequently Occurs in Gastrinomas and Is Correlated with Aggressive Tumor Growth",
abstract = "BACKGROUND. Recent studies have shown that tumor growth, rather than hormone overproduction, is the leading cause of death among patients with gastrinomas and other malignant gastrointestinal endocrine tumors. No patient/laboratory characteristics accurately predict which tumors will exhibit aggressive growth. Furthermore, little is known regarding the molecular pathogenesis of these tumors. X-chromosome loss of heterozygosity (LOH) occurs in some nonendocrine tumors, and its presence can be associated with aggressive growth/decreased survival. Data on X-chromosome LOH in gastrointestinal endocrine tumors are conflicting. Therefore, the purpose of the current study was to determine whether X-chromosome LOH occurred in gastrinomas and, if so, whether it was correlated with tumor growth, tumor behavior, and/or prognosis. METHODS. X chromosome allelotyping was performed using 12 microsatallite markers spaced throughout the chromosome using DNA from leukocytes and microdissected gastrinoma specimens from 16 female patients. The presence of X-chromosome LOH was analyzed for correlations with clinical and laboratory tumor characteristics as well as tumor growth characteristics. RESULTS. Nine gastrinoma specimens (56{\%}) had X-chromosome LOH, ranging from 6{\%} to 23{\%} at the 12 different loci studied. X-chromosome LOH was significantly associated with aggressive postoperative tumor growth, increased primary tumor size, and pancreatic primaries. In 6 tumor specimens, LOH occurred on Xp22.1-22.3 over a 28.4-centimorgan region. CONCLUSIONS. X-chromosome LOH was common in gastrinoma specimens from female patients, and its presence was found to be a potentially useful molecular/genetic prognostic factor for aggressive growth.",
keywords = "Loss of heterozygosity, Pancreatic endocrine tumors, Prognosis, Zollinger-Ellison syndrome",
author = "Chen, {Yuan Jia} and Alexander Vortmeyer and Zhengping Zhuang and Fathia Gibril and Jensen, {Robert T.}",
year = "2004",
month = "4",
day = "1",
doi = "10.1002/cncr.20104",
language = "English (US)",
volume = "100",
pages = "1379--1387",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - X-Chromosome Loss of Heterozygosity Frequently Occurs in Gastrinomas and Is Correlated with Aggressive Tumor Growth

AU - Chen, Yuan Jia

AU - Vortmeyer, Alexander

AU - Zhuang, Zhengping

AU - Gibril, Fathia

AU - Jensen, Robert T.

PY - 2004/4/1

Y1 - 2004/4/1

N2 - BACKGROUND. Recent studies have shown that tumor growth, rather than hormone overproduction, is the leading cause of death among patients with gastrinomas and other malignant gastrointestinal endocrine tumors. No patient/laboratory characteristics accurately predict which tumors will exhibit aggressive growth. Furthermore, little is known regarding the molecular pathogenesis of these tumors. X-chromosome loss of heterozygosity (LOH) occurs in some nonendocrine tumors, and its presence can be associated with aggressive growth/decreased survival. Data on X-chromosome LOH in gastrointestinal endocrine tumors are conflicting. Therefore, the purpose of the current study was to determine whether X-chromosome LOH occurred in gastrinomas and, if so, whether it was correlated with tumor growth, tumor behavior, and/or prognosis. METHODS. X chromosome allelotyping was performed using 12 microsatallite markers spaced throughout the chromosome using DNA from leukocytes and microdissected gastrinoma specimens from 16 female patients. The presence of X-chromosome LOH was analyzed for correlations with clinical and laboratory tumor characteristics as well as tumor growth characteristics. RESULTS. Nine gastrinoma specimens (56%) had X-chromosome LOH, ranging from 6% to 23% at the 12 different loci studied. X-chromosome LOH was significantly associated with aggressive postoperative tumor growth, increased primary tumor size, and pancreatic primaries. In 6 tumor specimens, LOH occurred on Xp22.1-22.3 over a 28.4-centimorgan region. CONCLUSIONS. X-chromosome LOH was common in gastrinoma specimens from female patients, and its presence was found to be a potentially useful molecular/genetic prognostic factor for aggressive growth.

AB - BACKGROUND. Recent studies have shown that tumor growth, rather than hormone overproduction, is the leading cause of death among patients with gastrinomas and other malignant gastrointestinal endocrine tumors. No patient/laboratory characteristics accurately predict which tumors will exhibit aggressive growth. Furthermore, little is known regarding the molecular pathogenesis of these tumors. X-chromosome loss of heterozygosity (LOH) occurs in some nonendocrine tumors, and its presence can be associated with aggressive growth/decreased survival. Data on X-chromosome LOH in gastrointestinal endocrine tumors are conflicting. Therefore, the purpose of the current study was to determine whether X-chromosome LOH occurred in gastrinomas and, if so, whether it was correlated with tumor growth, tumor behavior, and/or prognosis. METHODS. X chromosome allelotyping was performed using 12 microsatallite markers spaced throughout the chromosome using DNA from leukocytes and microdissected gastrinoma specimens from 16 female patients. The presence of X-chromosome LOH was analyzed for correlations with clinical and laboratory tumor characteristics as well as tumor growth characteristics. RESULTS. Nine gastrinoma specimens (56%) had X-chromosome LOH, ranging from 6% to 23% at the 12 different loci studied. X-chromosome LOH was significantly associated with aggressive postoperative tumor growth, increased primary tumor size, and pancreatic primaries. In 6 tumor specimens, LOH occurred on Xp22.1-22.3 over a 28.4-centimorgan region. CONCLUSIONS. X-chromosome LOH was common in gastrinoma specimens from female patients, and its presence was found to be a potentially useful molecular/genetic prognostic factor for aggressive growth.

KW - Loss of heterozygosity

KW - Pancreatic endocrine tumors

KW - Prognosis

KW - Zollinger-Ellison syndrome

UR - http://www.scopus.com/inward/record.url?scp=1642350310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642350310&partnerID=8YFLogxK

U2 - 10.1002/cncr.20104

DO - 10.1002/cncr.20104

M3 - Article

VL - 100

SP - 1379

EP - 1387

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 7

ER -